Actualités OSR Health Inc - OSRH | Actions NASDAQ

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

The tiered reward structure only has to be at or above the specified price level on the 3, 6, 9, or 12 month observation date.  It was...

Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

NEW YORK CITY, NY / ACCESS Newswire / July 2, 2026 / Emerging Growth Research today issued a flash report on OSR Health, Inc. (NASDAQ:OSRH...

OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares

Contingent Value Rights would reward continuous holders with additional shares as the Company meets defined price milestones BELLEVUE, WA / ACCESS...

OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do

BELLEVUE, WA / ACCESS Newswire / June 22, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced that it has officially changed its corporate...

CEO Statement to Shareholders

BELLEVUE, WA / ACCESS Newswire / June 3, 2026 / Dear Fellow Shareholders,As we move through 2026, I would like to provide an update on where OSR...

OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction

Transaction Centralizes VXM01 Ownership and Long-Term Royalty Economics at the OSRH Parent Level BELLEVUE, WA / ACCESS Newswire / May 27, 2026 /...

CEO Statement to Shareholders

A Clear Commitment: No Reverse Stock Split BELLEVUE, WA / ACCESS Newswire / May 12, 2026 / As many of our shareholders are aware, OSR Holdings...

Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target

NEW YORK, NY / ACCESS Newswire / May 5, 2026 / Emerging Growth Research today issued a flash report on OSR Holdings, Inc. (Nasdaq:OSRH...

OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026

OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026 BELLEVUE, WA / ACCESS Newswire / April 30, 2026 / OSR...

OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe

Largest shareholder pledges entire equity stake as collateral for milestone obligations, reinforcing alignment with public shareholders BELLEVUE...

OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note

BELLEVUE, WA / ACCESS Newswire / April 9, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) ("OSR Holdings" or the "Company") today...

OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026

BELLEVUE, WA / ACCESS Newswire / March 30, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company advancing biomedical...

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

NEW YORK CITY, NY / ACCESS Newswire / March 27, 2026 / Emerging Growth Research today issued a flash report on OSR Holdings, Inc. (Nasdaq:OSRH...

OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level

BELLEVUE, WA / ACCESS Newswire / March 23, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced an updated structure of its previously...

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials PR...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

OSR Health Inc (OSRH)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

OSR Health Inc (OSRH) Actualités

CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares

OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do

CEO Statement to Shareholders

OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction

CEO Statement to Shareholders

Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target

OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026

OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe

OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note

OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

OSR Health Inc (OSRH)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

OSR Health Inc (OSRH) Actualités

CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares

OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do

CEO Statement to Shareholders

OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction

CEO Statement to Shareholders

Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target

OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026

OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe

OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note

OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités